Related Experiment Video
Updated: Jun 20, 2026
A Microfluidic Platform for Stimulating Chondrocytes with Dynamic Compression
Published on: September 13, 2019
Micro-nano integrated platforms for osteoarthritis therapy: From spatial manipulation to cellular reprogramming
Zhijian Shi1,2, Jiayou Chen1,3, Haochi Lun1,3
1Department of Sports Medicine and Rehabilitation, Peking University Shenzhen Hospital, PKU-Shenzhen Clinical Institute of Shantou University Medical College, Shenzhen, Guangdong, 518036, PR China.
Micro-nano composite structures offer advanced osteoarthritis (OA) therapy by overcoming joint barriers for sustained drug delivery and tissue repair. These innovative platforms enable deep cartilage penetration and targeted immunomodulation, paving the way for precision regenerative medicine.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Materials Science
Background:
- Osteoarthritis (OA) treatment faces challenges from synovial clearance, cartilage matrix resistance, and inflammation.
- Conventional delivery systems fail to balance retention and deep tissue penetration.
- Micro-nano composite structures represent a new approach for modulating OA progression.
Purpose of the Study:
- To review advancements in micro-nano composite platforms for osteoarthritis therapy.
- To explore fabrication strategies and mechanisms of action for these trans-scale systems.
- To critically assess challenges and future directions for clinical translation.
Main Methods:
- Evaluation of fabrication techniques like microfluidics and 3D bioprinting.
- Analysis of mechanisms for prolonged joint residence and ECM infiltration.
- Assessment of immunomodulation of macrophages and stem cells.
Main Results:
- Micro-nano architectures can mimic native cartilage properties (topological, mechanical, biochemical).
- These systems stimulate endogenous repair mechanisms.
- Successful demonstration of cell-free therapy for OA with potential for regenerative medicine.
Conclusions:
- Micro-nano composite systems show promise for overcoming OA therapeutic barriers.
- Advanced fabrication enables precise control over structure and function.
- Further research is needed for clinical translation, focusing on scalability and biosafety.
